Cidara TherapeuticsCDTX
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 40 institutions reported holding Cidara Therapeutics Inc. (CDTX) in their 13F filings, up 13 from Q3 2024. 16 opened new positions and 4 sold out. The largest holders were BVF Inc. ($29.4M), Ra Capital Management, L.P. ($29.4M) and TCG Crossover Management, LLC ($26.1M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Cidara Therapeutics Inc.
- CUSIP
- 171757206
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 16 | $72.6M |
| Exits | 4 | $4.0M |
All 13F filers, Q3 2024 → Q4 2024: 4,004,587 shares bought and 439,366 shares sold, net +3,565,221 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 40 holders
| BVF Inc. | 1.00% | Add +55.4% | 1,092,796 | $29.4M |
| Ra Capital Management, L.P. | 0.39% | Add +55.4% | 1,092,796 | $29.4M |
| TCG Crossover Management, LLC | 2.55% | New | 1,005,901 | $26.1M |
| Venrock Adviser, LLC | 1.41% | New | 765,723 | $20.6M |
| Bain Capital Life Sciences Investors, LLC | 2.23% | No change | 703,080 | $18.9M |
| Vivo Capital, LLC | 2.02% | New | 670,600 | $18.0M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | Add +765.3% | 369,954 | $9.9M |
| Vanguard Group Inc. | 0.00% | Add +20.5% | 217,504 | $5.8M |
| Checkpoint Capital L.P. | 2.60% | Add +8.0% | 196,949 | $5.1M |
| Renaissance Technologies | 0.00% | Reduce -2.3% | 95,617 | $2.6M |
| 5AM Venture Management, LLC | 0.36% | No change | 56,725 | $1.5M |
| BlackRock, Inc. | 0.00% | Add +13.5% | 55,525 | $1.5M |
| Acuta Capital Partners, LLC | 1.47% | New | 54,473 | $1.5M |
| Ikarian Capital, LLC | 0.41% | New | 53,940 | $1.4M |
| Geode Capital Management, LLC | 0.00% | Add +0.3% | 53,068 | $1.4M |
| Schonfeld Strategic Advisors LLC | 0.01% | Add +154.1% | 49,557 | $1.3M |
| Stempoint Capital LP | 0.32% | New | 47,642 | $1.3M |
| UBS Group AG | 0.00% | Add +697.5% | 46,871 | $1.3M |
| Susquehanna International Group, LLP | 0.00% | New | 42,623 | $1.1M |
| Millennium Management | 0.00% | Add +158.3% | 35,960 | $967K |
| Northern Trust Corp. | 0.00% | Add +6.8% | 33,957 | $913K |
| ADAR1 Capital Management, LLC | 0.14% | New | 24,938 | $670K |
| State Street Corp. | 0.00% | Add +40.5% | 19,076 | $513K |
| Boothbay Fund Management, LLC | 0.01% | New | 15,601 | $419K |
| Alethea Capital Management, LLC | 0.33% | Reduce -82.1% | 14,311 | $385K |
| Goldman Sachs Group Inc. | 0.00% | New | 13,870 | $373K |
| Jane Street Group, LLC | 0.00% | New | 12,714 | $342K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 12,600 | $339K |
| Citigroup Inc. | 0.00% | New | 7,584 | $204K |
| Point72 Asset Management | 0.00% | New | 6,148 | $165K |
| Morgan Stanley | 0.00% | Add +1337.9% | 2,430 | $65K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | New | 2,085 | $56K |
| Manchester Capital Management LLC | 0.00% | No change | 470 | $13K |
| Avion Wealth | 0.00% | No change | 250 | $6K |
| Point72 (DIFC) Ltd | 0.00% | New | 198 | $5K |
| Bank of America Corp. | 0.00% | Add +28.2% | 50 | $1K |
| Allworth Financial LP | 0.00% | No change | 40 | $880 |
| SBI Securities Co., Ltd. | 0.00% | — | 20 | $538 |
| BNP Paribas Financial Markets | 0.00% | No change | 17 | $457 |
| JPMorgan Chase & Co. | 0.00% | Reduce -94.3% | 6 | $161 |
"% of holder's portfolio" is CDTX's weight in each manager's 13F, not the share of Cidara Therapeutics Inc. the manager owns.